Cargando…
Guidance on Short‐Term Management of Atrial Fibrillation in Coronavirus Disease 2019
Atrial fibrillation is a common clinical manifestation in hospitalized patients with coronavirus disease 2019 (COVID‐19). Medications used to treat atrial fibrillation, such as antiarrhythmic drugs and anticoagulants, may have significant drug interactions with emerging COVID‐19 treatments. Common u...
Autores principales: | Rattanawong, Pattara, Shen, Win, El Masry, Hicham, Sorajja, Dan, Srivathsan, Komandoor, Valverde, Arturo, Scott, Luis R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660727/ https://www.ncbi.nlm.nih.gov/pubmed/32515253 http://dx.doi.org/10.1161/JAHA.120.017529 |
Ejemplares similares
-
Empirical Ablation to Prevent Sequential Purkinje System Recruitment: A Novel Therapy for Idiopathic Ventricular Fibrillation
por: Rattanawong, Pattara, et al.
Publicado: (2021) -
Vaping tetrahydrocannabinol unmasks Brugada pattern and induces ventricular fibrillation in Brugada syndrome: a case report
por: Seri, Amith, et al.
Publicado: (2022) -
Pulmonary vein laceration during radiofrequency ablation for atrial fibrillation in a patient with previous robotic-assisted, minimally invasive mitral valve repair
por: Malan, Shawn H., et al.
Publicado: (2021) -
The efficacy of posterior wall isolation in atrial fibrillation ablation: A systematic review and meta‐analysis of randomized controlled trials
por: Kanitsoraphan, Chanavuth, et al.
Publicado: (2022) -
Adverse events in cryoballoon ablation for pulmonary vein isolation: Insight from the Food and Drug Administration Manufacturer and User Facility Device Experience
por: Tan, Min Choon, et al.
Publicado: (2023)